SLC5A2 and dementia: In the cohort of GLP1 receptor agonists versus SGLT2 inhibitors, the HR for all-cause dementia was 0.90 (95% CI: 0.75–1.07) among females, and the HR was 1.06 (95% CI: 0.91–1.24) among males; nonetheless, heterogeneity was not statistically significant (p = 0.163).